Interaction Between Type 2 Diabetes Prevention Strategies and Genetic Determinants of Coronary Artery Disease on Cardiometabolic Risk Factors

Publication Description
Coronary artery disease (CAD) is more frequent among individuals with dysglycemia. Preventive interventions for diabetes can improve cardiometabolic risk factors (CRFs), but it is unclear whether the benefits on CRFs are similar for individuals at different genetic risk for CAD. We built a 201-variant polygenic risk score (PRS) for CAD and tested for interaction with diabetes prevention strategies on one-year changes in CRFs in 2,658 Diabetes Prevention Program participants. We also examined whether separate lifestyle behaviors interact with PRS on changes in CRFs in each intervention group. Participants in both the lifestyle and metformin interventions had greater improvement in the majority of recognized CRFs compared to placebo (P0.05). We detected nominal significant interactions between PRS and dietary quality and physical activity on one-year change in body mass index, fasting glucose, triglycerides, and HDLc in individuals randomized to metformin or placebo, but none of them achieved the multiple-testing correction for significance. This study confirms that diabetes preventive interventions improve CRFs regardless of CAD genetic risk, and delivers hypothesis-generating data on the varying benefit of increasing physical activity and improving diet on intermediate cardiovascular risk factors depending on individual CAD genetic risk profile.

Primary Author
Merino,J.
Jablonski,K. A.
Mercader,J. M.
Kahn,S. E.
Chen,L.
Harden,M.
Delahanty,L. M.
Araneta,M. R. G.
Walford,G. A.
Jacobs,S. B. R.
Ibebuogu,U. N.
Franks,P. W.
Knowler,W. C.
Florez,J. C.
Diabetes Prevention Program Research Group

Author Address
Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.; Diabetes Unit, Massachusetts General Hospital, Boston, MA, USA.; Programs in Metabolism and Medical & Population Genetics, Broad Institute of MIT and Harvard, Cambrid(TRUNCATED)

Volume
69

Issue
1

Start Page
112

Other Pages
120

Publisher
by the American Diabetes Association

Author Address
Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA.; Diabetes Unit, Massachusetts General Hospital, Boston, MA, USA.; Programs in Metabolism and Medical & Population Genetics, Broad Institute of MIT and Harvard, Cambrid(TRUNCATED)

PMID
31636172

PMCID
PMC6925585



Reference Type
Journal Article

Periodical Full
Diabetes

Publication Year
2019

Publication Date
21-Oct

Place of Publication
United States

ISSN/ISBN
1939-327X

Document Object Index
10.2337/db19-0097

Accession Number
PMID: 31636172